Astrana Health (NASDAQ:ASTH) Raised to “Hold” at Zacks Research

Astrana Health (NASDAQ:ASTH) was upgraded by equities researchers at Zacks Research from a “strong sell” rating to a “hold” rating in a note issued to investors on Wednesday,Zacks.com reports.

Several other research analysts have also commented on ASTH. BTIG Research reduced their price objective on shares of Astrana Health from $45.00 to $40.00 and set a “buy” rating for the company in a research note on Monday, February 2nd. Barclays cut their price target on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating on the stock in a report on Monday, November 24th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Astrana Health in a research report on Monday, December 29th. Jefferies Financial Group reiterated a “buy” rating on shares of Astrana Health in a report on Tuesday, November 25th. Finally, Needham & Company LLC initiated coverage on Astrana Health in a research report on Friday, December 12th. They issued a “buy” rating and a $28.00 price objective for the company. Five analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Astrana Health presently has an average rating of “Moderate Buy” and an average price target of $35.33.

Astrana Health Price Performance

ASTH opened at $23.25 on Wednesday. The business’s 50-day moving average is $23.48 and its two-hundred day moving average is $26.03. Astrana Health has a 1 year low of $18.08 and a 1 year high of $34.80. The company has a debt-to-equity ratio of 1.25, a current ratio of 1.40 and a quick ratio of 1.40. The firm has a market capitalization of $1.31 billion, a PE ratio of 50.54 and a beta of 0.91.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Monday, March 2nd. The company reported $0.54 EPS for the quarter, beating the consensus estimate of $0.15 by $0.39. Astrana Health had a net margin of 0.71% and a return on equity of 5.59%. The business had revenue of $950.53 million during the quarter, compared to analyst estimates of $930.46 million. During the same period in the prior year, the firm posted ($0.15) earnings per share. The company’s quarterly revenue was up 42.9% on a year-over-year basis. Research analysts anticipate that Astrana Health will post 1.15 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of the stock. Signaturefd LLC raised its holdings in shares of Astrana Health by 57.9% in the fourth quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after buying an additional 388 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Astrana Health by 144.7% during the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after buying an additional 871 shares during the last quarter. Strs Ohio purchased a new stake in shares of Astrana Health during the fourth quarter valued at $40,000. Covestor Ltd increased its position in shares of Astrana Health by 210.6% in the 3rd quarter. Covestor Ltd now owns 3,233 shares of the company’s stock valued at $92,000 after acquiring an additional 2,192 shares during the period. Finally, Tower Research Capital LLC TRC raised its stake in Astrana Health by 323.3% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after acquiring an additional 3,517 shares during the last quarter. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.